New Brunswick, NJCIK 2004064 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
17 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc | 2.45M | $213.91M | 38.6% | 0 | Held |
| 2 | Nanobiotix | 5.62M | $130.02M | 23.4% | 0 | Held |
| 3 | Rapport Therapeutics Inc | 1.78M | $54.14M | 9.8% | 0 | Held |
| 4 |
| 6.64M |
| $52.80M |
| 9.5% |
| 0 |
| Held |
| 5 | Cvrx Inc | 4.02M | $28.58M | 5.2% | −78.6K | Reduced |
| 6 | Contineum Therapeutics Inc | 1.98M | $22.62M | 4.1% | 0 | Held |
| 7 | Legend Biotech Corp | 814.6K | $17.71M | 3.2% | 0 | Held |
| 8 | Xencor Inc | 748.1K | $11.45M | 2.1% | 0 | Held |
| 9 | Procept Biorobotics Corp | 357.9K | $11.26M | 2.0% | 0 | Held |
| 10 | Fate Therapeutics Inc | 3.38M | $3.32M | 0.6% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio